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Effect of Physical Activity on the Prevalence of
Metabolic Syndrome and Left Ventricular
Hypertrophy in Apparently Healthy Adults
Dao-Fu Dai,1 Juey-Jen Hwang,1 Chi-Ling Chen,2 Fu-Tien Chiang,3 Jiunn-Lee Lin,1 Kwan-Lih Hsu,1
Chuen-Den Tseng,1 Yung-Zu Tseng1*
Background/Purpose: Metabolic syndrome and left ventricular hypertrophy (LVH) carry high cardiovas-
cular risks. We performed a cross-sectional study to evaluate the effect of different amounts of physical 
activity (PA) on the prevalence of metabolic syndrome and LVH in our study population.
Methods: This study was a cross-sectional survey of 1494 apparently healthy subjects: 776 men with a
mean age of 57.6 ± 12.3 years, and 718 women with a mean age of 56.4 ± 11.0 years. The metabolic syn-
drome was defined according to modified criteria of the National Cholesterol Education Program Adult
Treatment Panel III. LVH was diagnosed by electrocardiography voltage criteria. The amount of PA was 
determined with a questionnaire and stratified into low, moderate or high levels.
Results: The prevalence of metabolic syndrome and its components was as follows: metabolic syndrome,
15.5%; obesity, 29.7%; high triglyceride level, 21.7%; low high-density lipoprotein–cholesterol level,
35.9%; high blood pressure, 56.9%; and impaired fasting glucose, 13.1%. A high amount of PA (> 14 km
per week walking distance) was significantly associated with lower prevalence of metabolic syndrome
[odds ratio (OR) = 0.53, p = 0.001], lower prevalence of obesity (OR = 0.56, p = 0.001), triglyceridemia
(OR = 0.58, p = 0.007) and LVH (OR = 0.37, p = 0.006). 
Conclusion: This study suggests that high amounts of PA are inversely correlated with the prevalence of
metabolic syndrome and LVH in men and women. 
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It is well known that metabolic syndrome in-
creases the risk of cardiovascular disease, which is
the leading cause of mortality and morbidity in
developed and developing countries. Metabolic
syndrome is characterized by obesity, glucose 
intolerance, elevated blood pressure and dyslipi-
demia. Each component of metabolic syndrome
predisposes people to atherosclerosis, and when
clustered together, these components promote
atherosclerosis even more prominently. Lifestyle
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modification, such as physical activity (PA) and
dietary habits, have been shown to reduce the
risk of cardiovascular diseases1–4 and the preva-
lence of metabolic syndrome.5–7 A sedentary life-
style predicts the development of metabolic
syndrome.8,9 However, the effect of different
amounts of moderate-intensity PA is unclear.
Left ventricular hypertrophy (LVH) is related
to the increased risk of cardiovascular disease and
mortality,10 as well as stroke and transient ischemic
attack.11 It has been demonstrated to be an inde-
pendent predictor of cardiovascular events.12 The
effect of PA on LVH is not completely understood.
Strenuous PA is known to cause LVH and dilata-
tion as normal physiologic adaptations in ath-
letes.13,14 Conversely, low-to-moderate-intensity
exercise has been shown to decrease blood pres-
sure and regression of LVH in subjects with severe
hypertension.15 However, the effect of different
amounts of PA on LVH in the general population
remains unknown. 
Metabolic syndrome is known to be a risk factor
for cardiovascular disease and it has been exten-
sively studied in the western hemisphere. How-
ever, the data for the Taiwanese population are
limited. Therefore, we carried out a cross-sectional
population study to elucidate the prevalence 
of metabolic syndrome in Taiwan. Furthermore,
we wanted to investigate the association of vari-
ous amounts of PA on the prevalence of meta-
bolic syndrome and LVH in our middle-aged
population. 
Materials and Methods
Recruitment of study participants
We recruited 1494 apparently healthy subjects
aged >40 years in 1992–1993. These subjects com-
prised 776 men with a mean age of 57.6 ± 12.3
years, and 718 women with a mean age of 56.4 ±
11.0 years from Taipei city (1992) and San-Tze
village (1993), a suburban area of Taipei (1042
and 452 subjects, respectively). All subjects were
randomly selected from the general population
in those areas. We randomly selected one out of
every 100 administrative units in Taipei and San-Tze
village. All participants provided informed consent
before enrollment. A detailed medical record was
obtained, which included basic personal and demo-
graphical data, complete medical history including
current medication use and smoking status, edu-
cational level, and menopausal status for women.
Physical examination, including measurement of
body weight and height, was performed for the
individual participants. Sitting blood pressure was
measured three times with a conventional sphyg-
momanometer. Study subjects were instructed to
fast for 12 hours overnight, and blood samples
were collected for biochemistry tests, including
fasting blood glucose, lipid profiles and uric acid,
using standard laboratory methods in the hospital.
Definition of metabolic syndrome and left
ventricular hypertrophy
Metabolic syndrome was defined according to
the criteria of the National Cholesterol Education
Program Adult Treatment Panel III with slight
modification. Subjects with metabolic syndrome
had three or more of the following criteria: obesity
[body mass index (BMI) ≥ 27 kg/m2]; serum tri-
glycerides ≥150 mg/dL (1.7 mmol/L); serum high-
density lipoprotein (HDL)-cholesterol < 40 mg/dL
(1.04 mmol/L) in men or <50 mg/dL (1.29 mmol/
L) in women; blood pressure ≥ 130/85 mmHg 
or hypertensive patients taking regular medica-
tion; and fasting plasma glucose ≥ 110 mg/dL
(6.1 mmol/L) or diabetic patients taking regular
hypoglycemic agents.
LVH was diagnosed by 12-lead electrocardiog-
raphy according to Framingham voltage criteria12
as follows: R aVL > 11 mm and R V4–6 > 25 mm,
or S V1–3 > 25 mm, or S V1 or V2 + R V5 or V6 >
35 mm, or R I + S III > 25 mm. The diagnosis of
LVH was made by two independent cardiologists
with an inter-rater agreement of 99.7%.
Assessment of daily PA
Daily PA was evaluated with a semi-quantitative
questionnaire to assess the amount of daily PA
in the previous month. The questionnaire asked:
“How far do you walk every day on average? 
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(a) <0.5km (500m); (b) between 500m and 2km;
or (c) > 2 km.” We applied the reported walking
distance as a rough measurement of the amount
of daily PA.16 Based on their weekly walking dis-
tance, all participants were classified into three
categories: sedentary life (low amount of PA);
walking < 3.5 km per week; moderate amount 
of PA, walking 3.5–14 km per week; and high
amount of PA, walking > 14 km per week.
Statistical analysis
To analyze the prevalence of metabolic syndrome,
we divided our study population into four age
categories: 40–49, 50–59, 60–69, and ≥ 70 years.
The prevalence of metabolic syndrome in each
age category was calculated separately for men and
women. Continuous variables were presented as
mean± standard deviation and categorical variables
were reported as percentages. Differences between
mean values were assessed by Student’s t test and
differences between proportions were calculated
by the χ2 test. One-way analysis of variance was
used to compare the mean values of each meta-
bolic factor as continuous variables across different
PA categories. To determine the effects of different
amounts of moderate-intensity PA on the preva-
lence of metabolic syndrome and its components,
as well as LVH, we applied multiple logistic regres-
sion analyses with adjustments for sex, age and
smoking habits. The odds ratio (OR) was calculated
using the low amount of moderate-intensity PA
(sedentary lifestyle) group as a reference. Further
stratified analysis for men and women was per-
formed with logistic regression with adjustments
for age, smoking and menopausal status (for
women). A two-tailed p value of < 0.05 was con-
sidered significant. STATA Intercooled version 7.0
(StataCorp, College Station, TX, USA) was used
for all statistical calculations.
Results
Epidemiology of metabolic syndrome
The overall prevalence of metabolic syndrome
according to the modified criteria of the National
Cholesterol Education Program Adult Treatment
Panel III was 15.5% and the age-standardized
prevalence was 14.7% (World Health Organiza-
tion World Standard Population 2000). Figure 1
shows that the prevalence of metabolic syndrome
significantly increased with age for both sexes.
The prevalence of metabolic syndrome in men for
the different age groups was as follows: 10.7% in
40–49 years, 16.6% in 50–59 years, 21.0% in
60–69 years, and 19.6% in > 70 years. In women,
the prevalence of metabolic syndrome in the dif-
ferent age groups was: 7.2% in 40–49 years, 11.9%
in 50–59 years, 22.2% in 60–69 years, and 22.7%
in > 70 years. These data demonstrated that men
had higher prevalence of metabolic syndrome
than women in the age groups 40–49 years and
50–59 years (p = 0.19 and 0.01, respectively). Con-
versely, women had slightly higher prevalence of
metabolic syndrome in the age group 60–69 years
or older, although the differences were not statis-
tically significant.
High blood pressure (>130/85 mmHg) was the
most common metabolic abnormality (56.9%),
followed by low HDL-cholesterol (35.9%), obe-
sity (29.7%), high triglyceride level (21.7%), and
impaired fasting glucose (13.1%). Table 1 shows
the prevalence of each component of metabolic
syndrome stratified by age group and sex. In
women, all components of metabolic syndrome
increased significantly after postmenopausal age,
whereas in men, only the prevalence of high blood
pressure and impaired fasting glucose increased
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Figure 1. Prevalence of metabolic syndrome in Taiwanese
population in 1993.
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with older age. In the 40–49-year-old age group,
the prevalence of obesity, low HDL-cholesterol
and impaired fasting glucose was similar for men
and women; hypertriglyceridemia and high blood
pressure were even more common in men (23.7%
vs. 9.9%, p < 0.01 and 45.2% vs. 36.4%, p = 0.05,
respectively). However, the reverse was noted after
postmenopausal age, when women had signif-
icantly higher prevalence of obesity (37.1% vs.
26.3%, p = 0.02). The prevalence of all other com-
ponents of metabolic syndrome was similar be-
tween men and women.
Association of different amounts of PA with
prevalence of metabolic syndrome and LVH
Baseline characteristics of the participants are
shown in Table 2. Compared with controls, sub-
jects with metabolic syndrome were significantly
older (59.7 ± 11.7 vs. 56.6 ± 11.6 years, p < 0.001).
These subjects also had higher serum total cho-
lesterol (200.6±40.5mg/dL vs. 188.0±46.0mg/dL,
p < 0.001), were more likely to be smokers (30.7%
vs. 22.4%, p = 0.05), and were less physically ac-
tive (24.7% vs. 17.8%, p = 0.04). Sex distribution
was similar for metabolic syndrome and controls.
Table 3 displays the effect of different amounts
of moderate-intensity PA on the profiles of sev-
eral metabolic parameters. High amounts of PA
were significantly associated with lower BMI (p =
0.04), lower triglyceride level (p = 0.02) and higher
HDL-cholesterol in women (p < 0.01). No obvious
difference was noted for the remaining metabolic
factors.
As shown in Figure 2, subjects with high
amounts of PA had lower prevalence of meta-
bolic syndrome. These phenomena were valid for
men and women. After adjustment for age, sex
and smoking habit, multiple logistic regression
analyses showed that, when compared with seden-
tary lifestyle, high amounts of PA were associated
with decreased risk of metabolic syndrome [OR =
0.61, 95% confidence interval (CI) = 0.36–0.86,
p = 0.001], but moderate amounts of PA had no
significant risk reduction (OR = 0.83, 95% CI =
0.56–1.23, p = 0.40) (Table 4). For each compo-
nent of metabolic syndrome, a high amount PA
was significantly associated with lower prevalence
of obesity (OR = 0.56, p = 0.001), hypertriglyc-
eridemia (OR = 0.58, p = 0.007) and low HDL-
cholesterol (OR = 0.73, p = 0.05). These effects
were not observed in the moderate PA group.
The level of PA had no significant association
with high blood pressure or impaired fasting
glucose. 
Multiple logistic regression analysis revealed
that LVH was correlated with systolic blood pres-
sure (OR = 1.3, p < 0.01) (data not shown), and
inversely associated with high amounts of PA
(OR =0.40, 95% CI=0.18–0.83, p=0.01) (Table 4)
after controlling for sex, age, BMI, blood pressure,
Table 1. The prevalence of each component of the metabolic syndrome stratified by age and sex*
Age (yr)
Metabolic factors Sex n
40–49 50–59 60–69 ≥ 70
p
Obesity, BMI ≥ 27 kg/m2 M 199 22.3 26.3 25.6 30.1 0.42
F 245 22.1 37.1* 38.6* 46.4* < 0.01
Triglycerides ≥ 150 mg/dL M 194 23.7 32.6 21.5 23.1 0.07
F 130 9.9* 15.2* 27.0 25.8 < 0.01
HDL-cholesterol < 40 mg/dL M 254 33.3 30.1 34.8 33.8 0.78
HDL-cholesterol < 50 mg/dL F 283 33.0 39.7 42.8 50.5* 0.03
Blood pressure ≥ 130/85 mmHg M 459 45.2 58.4 67.1 71.3 < 0.01
F 391 36.4* 56.0 64.2 76.3 < 0.01
Fasting blood glucose ≥ 110 mg/dL M 115 8.6 18.0 16.3 19.0 0.01
F 82 5.0 12.3 17.1 13.4 < 0.01
*p < 0.05 between men and women. BMI = body mass index; HDL = high-density lipoprotein.
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and smoking habits. Moderate PA did not have a
significant correlation with prevalence of LVH.
Separate analyses for men and women revealed 
a similar trend for the inverse correlation be-
tween high PA and prevalence of metabolic syn-
drome and its components, except that high PA
was significantly associated with lower prevalence
of high BP in men (OR = 0.61, p = 0.05) but not
in women (Table 5). The benefit of high PA on
the prevalence of LVH seemed to be greater in
women than in men (OR = 0.20 in women and
0.43 in men) (Table 5).
Table 2. Baseline characteristics of study population, with and without the metabolic syndrome*
Overall (n = 1494) Without MS (n = 1263) With MS (n = 231) p
Age (yr) 57.1 ± 11.7 56.6 ± 11.6 59.7 ± 11.7 < 0.001
Sex
Male 776 648 (83.5) 128 (16.5)
Female 718 615 (85.7) 103 (14.3) 0.250
Systolic BP (mmHg) 128.8 ± 20.0 126.5 ± 19.5 141.9 ± 19.1 < 0.001
Diastolic BP (mmHg) 81.6 ± 11.0 80.4 ± 10.5 88.1 ± 11.3 < 0.001
BMI (kg/m2) 24.2 ± 3.5 23.7 ± 3.1 26.6 ± 4.1 < 0.001
Serum HDL cholesterol (mg/dL) 50.0 ± 15.2 52.4 ± 14.9 36.8 ± 8.8 < 0.001
Serum triglycerides (mg/dL) 116.4 ± 80.6 100.0 ± 56.2 216.9 ± 113.4 < 0.001
Fasting blood glucose (mg/dL) 95.5 ± 35.0 92.3 ± 34.5 113.3 ± 42.2 < 0.001
Serum total cholesterol (mg/dL) 190.0 ± 45.4 188.0 ± 46.0 200.6 ± 40.5 < 0.001
Serum uric acid (mg/dL) 6.4 ± 13.2 6.4 ± 1.4 6.9 ± 1.8 0.570
Prevalence of hypertension 266 (17.8) 182 (14.4) 84 (36.4) < 0.001
Prevalence of diabetes 87 (5.8) 45 (3.6) 42 (18.2) < 0.001
Prevalence of smoking 354 (23.7) 283 (22.4) 71 (30.7) 0.050
Amount of PA
High 502 (33.6) 434 (34.4) 68 (29.4)
Moderate 710 (47.5) 589 (46.6) 121 (52.4)
Low (sedentary lifestyle) 282 (18.9) 225 (17.8) 57 (24.7) 0.070
*Data presented as n (%) or mean ± standard deviation. MS = metabolic syndrome; BP = blood pressure; PA = physical activity.
Table 3. Effects of the amount of physical activity on various metabolic factors*
Sedentary Moderate PA High PA p
BMI (kg/m2) 25.4 ± 3.5 24.1 ± 3.4 23.1 ± 3.4 0.04
HDL-cholesterol (mg/dL)
Male 44.4 ± 13.4 46.0 ± 14.8 47.5 ± 14.1 0.11
Female 51.3 ± 13.7 55.0 ± 15.3 55.8 ± 18.5 < 0.01
Triglycerides (mg/dL) 127.0 ± 93.4 120.2 ± 78.0 110.3 ± 71.0 0.02
Fasting glucose (mg/dL) 93.2 ± 25.4 96.7 ± 30.0 94.6 ± 33.2 0.51
Systolic BP 131.0 ± 22.0 129.2 ± 20.0 130.2 ± 19.8 0.18
Diastolic BP 82.1 ± 11.0 82.3 ± 11.0 81.2 ± 10.0 0.27
Uric acid (mg/dL) 6.0 ± 1.8 6.2 ± 1.7 6.0 ± 1.6 0.17
*Data presented as mean ± standard deviation. BMI = body mass index; BP = blood pressure; PA = physical activity.
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Discussion
The age-adjusted prevalence of metabolic syn-
drome in our population was 14.65%, which was
clearly lower than that reported in the American
(24.0%),17 Asian Indian (41.1%),18 Arab American
(23.0%)19 and Iranian (33.7%) populations.20
It was obvious that the prevalence of metabolic
syndrome increased with age for both sexes. In
younger age groups, men had higher prevalence of
metabolic syndrome than women had, whereas
women after postmenopausal age had a higher
prevalence of metabolic syndrome than men.
This phenomenon could be attributed to the
protective effect of estrogen during the reproductive
age of women, in parallel with the well-known
lower cardiovascular risks in premenopausal
women. Among the metabolic syndrome traits,
high normal blood pressure was the most com-
mon in our middle age population (56.9%), fol-
lowed by low HDL-cholesterol (35.9%), obesity
(29.7%), high triglyceride level (21.7%), and im-
paired fasting glucose (13.1%). Likewise, high
blood pressure was also the most common among
the metabolic syndrome traits in middle-aged
Asian Indian19 and Iranian20 populations. These
findings are in contrast with the prevalence of
metabolic abnormalities in the United States pop-
ulation reported in the National Health and
Nutrition Examination Survey III,18 in which ab-
dominal obesity (38.6%) and low HDL-cholesterol
(37.1%) were more prevalent than high normal
blood pressure (34.0%). With regard to the racial
differences, the frequencies of metabolic abnor-
malities in Taiwanese resemble those in African
Americans, rather than those in Caucasians and
Mexican Americans.
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Figure 2. Prevalence of metabolic syndrome stratified by
amount of physical activity. PA = physical activity.
Table 4. Effect of moderate and high amount of physical activity on the prevalence of the metabolic syndrome,
its components and the prevalence of left ventricular hypertrophy, after adjustments for sex, age
and smoking habit
PA OR (95% CI) p
Metabolic syndrome Moderate 0.83 (0.56–1.23) 0.400
High 0.61 (0.36–0.86) 0.010
Obesity, BMI > 27 kg/m2 Moderate 0.73 (0.53–1.00) 0.050
High 0.56 (0.40–0.80) 0.001
Low HDL-cholesterol Moderate 0.81 (0.58–1.14) 0.210
High 0.73 (0.53–1.00) 0.050
High triglycerides Moderate 0.87 (0.61–1.23) 0.460
High 0.58 (0.39–0.86) 0.007
High BP Moderate 0.91 (0.65–1.27) 0.610
High 0.78 (0.55–1.11) 0.190
Impaired fasting glucose Moderate 1.33 (0.84–2.11) 0.210
High 0.88 (0.54–1.45) 0.630
LVH* Moderate 0.77 (0.43–1.40) 0.390
High 0.40 (0.18–0.83) 0.010
*Also adjusted for systolic and diastolic BP and BMI. BMI = body mass index; BP = blood pressure; OR = odds ratio; CI = confidence 
interval; LVH = left ventricular hypertrophy.
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In the present cross-sectional study, we com-
pared the association of three different amounts
of PA with overall prevalence of metabolic syn-
drome and its components. We found that the
prevalence of metabolic syndrome was lower in
the high PA group (walking at least 14 km per
week). However, the association was not observed
in subjects with moderate or low PA (walking
< 14 km per week). This result indicated that a
high amount of PA was inversely correlated with
risk of metabolic syndrome if the amount of daily
PA exceeded 14 km per week walking distance.
Moderate amounts of PA were not associated with
reduced prevalence of metabolic syndrome. After
stratification for each component of metabolic
syndrome, we found that prevalence of obesity
and hypertriglyceridemia, but not other compo-
nents, was significantly reduced in the high-PA
group. This result was consistent with the finding
of previous study by Kraus et al,21 which showed
that high amounts of PA (average 17.4 km per
week) had greater benefit than low-to-moderate
amounts of PA (average 11 km per week) in terms
of lipid profiles, and both high and low amounts
of PA were beneficial when compared with the
sedentary group. The low amount of PA in the
study of Kraus et al is equivalent to high PA in
our study. The amount of PA in our study ranged
from < 3.5 km per week to > 14 km per week,
which could be regarded as being the lower ex-
tension of the PA spectrum used by Kraus et al.
The beneficial effect of walking was also reported
in a substudy of the Women’s Health Initiative
Observational Study, which demonstrated that
walking was associated with a similar reduction
in risk of cardiovascular events as vigorous exer-
cise among postmenopausal women. Moreover,
a brisker walking pace and fewer hours spent 
sitting daily also predicted lower risks.22
We applied BMI instead of waist circumference
as a criterion for metabolic syndrome in this study.
Although obesity (defined by BMI) and abdominal
obesity (defined by waist circumference) are not
interchangeable, several studies have confirmed
their close correlation.23 Furthermore, BMI and
waist circumference are independent predictors of
cardiovascular risk profiles.24 In addition, our study
also revealed that high-to-moderate-intensity PA
was associated with less LVH, after control for
confounding factors, such as blood pressure, BMI,
sex, age and menopausal status. Likewise, this
benefit was absent in the group with a moderate
amount of moderate-intensity PA.
A previous study has shown that athletes who
undertake regular vigorous PA have LVH and di-
latation.14 In contrast, hypertensive subjects who
take regular low-to-moderate-intensity PA have
been shown to have regression of LVH.8 This dis-
crepancy suggests that the intensity of PA, in ad-
dition to the amount, is another important factor
that affects LVH. We demonstrated that high
amounts of PA were significantly associated with
decreased prevalence of LVH, even though it did
not seem to be associated with decreased blood
Table 5. Effect of high amount of PA on the prevalence of the metabolic syndrome, its components and the
prevalence of left ventricular hypertrophy stratified for men and women, after adjustments for age,
smoking habit and menopausal status (for women)*
Male p Female p
Metabolic syndrome 0.63 (0.35–1.01) 0.05 0.52 (0.27–0.98) 0.05
Obesity, BMI > 27 kg/m2 0.54 (0.33–0.88) 0.01 0.61 (0.37–0.99) 0.05
Low HDL-cholesterol 0.72 (0.51–1.01) 0.05 0.54 (0.34–0.86) 0.01
High triglycerides 0.61 (0.36–0.98) 0.04 0.60 (0.32–1.00) 0.05
High BP 0.61 (0.37–1.00) 0.05 0.84 (0.52–1.37) 0.50
Impaired fasting glucose 1.04 (0.53–2.05) 0.14 0.75 (0.35–1.58) 0.45
LVH 0.43 (0.20–0.99) 0.05 0.20 (0.05–0.81) 0.02
*Data presented as odds ratio (95% confidence interval). BMI = body mass index; HDL = high-density lipoprotein; BP = blood pressure;
LVH = left ventricular hypertrophy.
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pressure. Although it is well known that high
blood pressure induces LVH, we propose three
explanations for the benefit of high PA in rela-
tion to reduced LVH prevalence, independent of
blood pressure. First, it is well known that per-
sons who regularly undertake high amounts of
PA have slower resting heart rate. The oversimpli-
fied physiological explanation is that slower heart
rate reduces the overall cardiac workload and
subsequently prevents LVH. Conversely, high-
intensity PA in athletes imposes greater stress on
the heart, which might subsequently induce LVH,
denoted as physiological cardiac hypertrophy.
Second, Braith et al25 reported that subjects with
regular training programs have lower plasma lev-
els of catecholamines, angiotensin II, arginine
vasopressin, and aldosterone. This suppression
of neurohormonal stimulation might attenuate
the progression of LVH. Third, PA has been re-
ported to increase endogenous antioxidant defense
capacity, which plays an important role in the
development of LVH.26 However, further studies
are needed to elucidate the exact mechanism
that underlies the correlation of PA and LVH.
Although our study was based on an epidemi-
ological survey carried out more than 15 years
ago, we did demonstrate the beneficial effect of
high amounts of PA on the prevalence of meta-
bolic syndrome and LVH, and this was not likely
to have changed with time. Furthermore, com-
parison of our data with a recent report by Chen
et al revealed that the prevalence of metabolic
syndrome in Taiwan has increased dramatically
during the past decade.27 This underlines an ur-
gent need to develop a better strategy to prevent
metabolic syndrome and cardiovascular diseases.
There are several limitations to our study. First,
we used a questionnaire to document the aver-
age daily walking distance in the previous month,
which could have induced a recall bias. Further-
more, the recalled daily walking distance might
only have provided a rough estimate and not the
overall PA of an individual. Objective measure-
ment with exercise prescription in a prospective
study21 would be more reliable than a question-
naire-based method in a cross-sectional study.
Second, we did not include some potential con-
founders, such as diet and socioeconomic status.
However, in a large-scale epidemiological study,
these data were also based on self-reported ques-
tionnaires, which again, could have introduced
bias. Third, our retrospective study design could
not address the causal effect relationship between
PA and metabolic syndrome or LVH.
In summary, metabolic syndrome is prevalent
in Taiwan, although the prevalence in our middle-
aged population seems to be lower than that 
reported in western and other Asian populations.
Higher amounts of PA are inversely correlated
with prevalence of metabolic syndrome and LVH.
However, this beneficial effect is seen only if the
amount of PA exceeds the walking distance of
14 km per week. Future studies are required to
elucidate the mechanisms that underlie the cor-
relation between LVH and PA.
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